Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
University of California, San Francisco
Medical College of Wisconsin
Bergman Clinics
Osijek University Hospital
George Washington University
University of Chicago
Grupo Español de Investigación en Cáncer de Ovario
Grupo Espanol de Tumores Neuroendocrinos
Abramson Cancer Center at Penn Medicine
Vanderbilt University Medical Center
Fundación GECP
Mayo Clinic
Children's Hospital of Philadelphia
Milton S. Hershey Medical Center
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Institut Bergonié
Ottawa Hospital Research Institute
Centre Francois Baclesse
Memorial Sloan Kettering Cancer Center
Universitätsmedizin Mannheim
CHA University
Institut Bergonié
Institut Bergonié
Institut Bergonié
Institut Bergonié
Institut Bergonié
Centre Hospitalier Departemental Vendee
M.D. Anderson Cancer Center
University of Washington
University of Utah
Institut Bergonié
Institut Bergonié
Institut Bergonié
Institut Bergonié
Institut Bergonié
Institut Bergonié
Addario Lung Cancer Medical Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Institut Bergonié
Masonic Cancer Center, University of Minnesota
Institut Bergonié
Institut Bergonié
Wuerzburg University Hospital
Royal Marsden NHS Foundation Trust
Mayo Clinic
Academic and Community Cancer Research United
Institut Bergonié
Oxford University Hospitals NHS Trust
Royal Marsden NHS Foundation Trust